人口学与肿瘤特征对少数族裔缺医少药人群喉癌结局的影响
该回顾性队列研究纳入2005至2015年间在休斯敦县医院新诊断的210例喉鳞状细胞癌患者,多数为少数族裔且缺医少保。结果显示43%为T4期、45%有淋巴结转移,81%治疗符合NCCN指南,但76%需辅助放疗者术后6周内未能开始。全队列总生存率和无病生存率分别为52%和63%,声门上亚部位和淋巴结转移与生存下降显著相关,而种族/民族和保险状态与肿瘤结局无关。
要点
- 缺医少保患者常以晚期喉癌就诊(T4占43%,N>0占45%)。
- 81%治疗符合NCCN指南,但76%需辅助放疗者术后6周内未启动。
- 肿瘤特征而非人口学变量驱动肿瘤结局。
核心结论
- 在少数族裔和缺医少药人群中,肿瘤特征而非种族/民族或保险状态驱动喉癌肿瘤结局。
- 该队列肿瘤结局与其他已发表系列相似。
研究设计与样本
- 回顾性队列研究,纳入2005至2015年间在休斯敦三级县医院新诊断的210例喉鳞状细胞癌患者。
主要发现
- 43%患者为T4期,45%有淋巴结转移(N>0)。
- 81%病例治疗选择符合NCCN指南。
- 76%需要辅助放疗的患者术后6周内未能开始放疗。
- 全队列总生存率为52%,无病生存率为63%。
- 声门上亚部位和淋巴结转移与总生存率和无病生存率下降显著相关。
关键数值与推荐
- 治疗选择符合NCCN指南的比例为81%。
- 需要辅助放疗的患者中76%未能在术后6周内开始放疗。
临床怎么用
- 对缺医少保的喉癌患者应关注肿瘤分期和淋巴结状态以评估预后。
- 需优化辅助放疗的启动时机,减少术后延迟。
局限性
- 单中心回顾性研究,样本来自县医院特定人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Advanced laryngeal squamous cell carcinoma remains associated with approximately 50% mortality at 5 years. Delivery of multimodality treatment remains critical to maximizing survival for this disease, but achieving this at a national level remains a difficult undertaking, particularly in under- and uninsured patients as well as minority patients. We sought to evaluate laryngeal cancer treatment delivery and clinical outcomes in a predominantly minority and underserved cohort of largely under- and uninsured patients in a county hospital. STUDY DESIGN: Retrospective cohort study. SETTING: Tertiary care county hospital in Houston, Texas. SUBJECTS AND METHODS: Patients (N = 210) with a new diagnosis of laryngeal squamous cell carcinoma treated between 2005 and 2015 were included in a retrospective analysis of patient demographics, tumor and treatment characteristics, and oncologic outcomes. RESULTS: The majority of patients presented with advanced disease (T4 = 43%, N>0 = 45%). Treatment selection was compliant with National Comprehensive Cancer Network guidelines in 81% of cases, but 76% of patients who required adjuvant radiotherapy were unable to start it within 6 weeks postsurgery. Overall survival and disease-free survival were 52% and 63% for the entire cohort, respectively. Supraglottic subsite and nodal metastases were significantly associated with decreased overall survival and disease-free survival. Race/ethnicity and insurance status were not associated with worse oncologic outcomes. CONCLUSION: Under- and uninsured patients often present with advanced laryngeal cancer. Oncologic outcomes in this cohort of patients is similar to that of other published series. Moreover, tumor characteristics rather than demographic variables drive oncologic outcomes for the predominantly minority and underserved patients seeking care in our tertiary care county hospital.
引用
- Fullmer T, Wilde DC, Shi JW, et al. Demographic and Tumor Characteristic Impact on Laryngeal Cancer Outcomes in a Minority Underserved Patient Population. Otolaryngol Head Neck Surg. 2020. PMID: 32093532. doi:10.1177/0194599820907064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。